This inventor holds 1 USPTO granted patent. Top assignee: Qiagen Gmbh. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Luc Reymond: Innovator in RNA Technology
Introduction
Luc Reymond is a notable inventor based in Chavannes, Switzerland. He has made significant contributions to the field of molecular biology, particularly in the development of RNA technologies. His innovative work has led to the creation of a patented invention that holds promise for various applications in genetic research and therapeutics.
Latest Patents
Luc Reymond holds a patent for a modified short interfering RNA (siRNA) molecule. This invention refers to a double-stranded siRNA that comprises a sense strand and an antisense strand, which is essentially complementary to the sense strand. Each strand consists of at least 17 nucleotides, and the siRNA includes at least one overhang at the 5' and/or 3' end. The overhang residues are chemically modified and selected independently from a specific group of modifications, enhancing the functionality of the siRNA.
Career Highlights
Luc Reymond is currently associated with Qiagen GmbH, a leading company in the field of molecular diagnostics and sample preparation. His work at Qiagen has allowed him to focus on innovative solutions that advance the understanding and application of RNA technologies. His patent reflects his commitment to pushing the boundaries of scientific research.
Collaborations
Throughout his career, Luc Reymond has collaborated with esteemed colleagues, including Stefan Pitsch and Ioanna Andreou. These collaborations have fostered a dynamic environment for innovation and have contributed to the advancement of their shared research goals.
Conclusion
Luc Reymond's contributions to RNA technology exemplify the impact of innovative thinking in the scientific community. His patented invention of modified siRNA molecules showcases his dedication to advancing molecular biology. Through his work at Qiagen and collaborations with fellow researchers, he continues to influence the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
